Clorox
Clorox sells household cleaning and disinfecting products, garbage bags, food dressings, cat litter, water filters, and personal care products through brands such as Clorox, Pine-Sol, Glad, Hidden Valley, Brita, and Burt’s Bees. Its Health and Wellness segment, particularly cleaning and disinfecting products, is a key area analysts focus on.
高乐氏(The Clorox Company)销售家居清洁与消毒产品、垃圾袋、沙拉酱、猫砂、净水过滤产品及个人护理用品,旗下品牌包括 Clorox、Pine-Sol、Glad、Hidden Valley、Brita 和 Burt’s Bees。其健康与保健业务部门,尤其是清洁与消毒产品,是分析师重点关注的领域。
Every figure on this page is tipranks’s, read on 2026-10-27 and linked below.
SmartChecker Clorox Forecast
The forecast in short
tipranks records 14 analyst ratings on Clorox and summarises them as “Moderate Sell”. Their average 12-month price target is USD 90.15 (3.91% Upside). Its tipranks score is 3 out of 10 — Underperform. These are tipranks’s figures as SmartChecker read them on 2026-10-27, not SmartChecker’s own view, and nothing here is advice to buy or sell.
Market cap
USD 10.49 B
≈ Maybank x 0.35
Share price
USD 86.76
≈ RM 354.58
#1926World ranking
tipranks score
Underperform
Analyst ratings
Moderate Sell
- Buy0 0%
- Hold10 71%
- Sell4 29%
tipranks’s own summary of the 14 ratings above.
12 months price forecast
USD 90.15 3.91% Upside
As tipranks publishes it. SmartChecker has not recalculated any of it.
Analyst profiles. Who made each call, and when.
| Analyst | From | Position | Target price | Dated |
|---|---|---|---|---|
| Peter Grom | UBS | Hold | USD 91 | 2026-10-26 |
| Andrea Faria Teixeira | J.P. Morgan | Sell | USD 83 | 2026-10-19 |
| Stephen Powers | Deutsche Bank | Hold | USD 95 | 2026-10-19 |
| Lauren Lieberman | Barclays | Sell | USD 80 | 2026-10-16 |
| Filippo Falorni | Citi | Hold | USD 90 | 2026-10-15 |
| Dara Mohsenian | Morgan Stanley | Hold | USD 87 | 2026-10-15 |
| Robert Moskow | TD Cowen | Hold | USD 80 | 2026-10-13 |
| Nik Modi | RBC Capital | Hold | USD 110 | 2026-10-06 |
| Christopher Carey | Wells Fargo | Hold | USD 85 | 2026-10-05 |
| Bonnie Herzog | Goldman Sachs | Sell | USD 74 | 2026-10-05 |
| Anna Lizzul | Bank of America Securities | Hold | USD 100 | 2026-09-18 |
| Javier Escalante | Evercore ISI | Sell | USD 99 | 2026-09-11 |
| Taylor Conrad | Argus Research | Hold | N/A | 2026-08-18 |
| Kaumil Gajrawala | Jefferies | Hold | USD 98 | 2026-07-28 |
| Edward Lewis | Rothschild & Co Redburn | Hold | USD 117 | 2026-02-13 |
Show moreShow less
Investment Strengths
Market Share Momentum
Repeated share gains in Home Care, Pro, and International indicate that several important businesses are defending or expanding their competitive positions. This supports retailer relevance, brand durability, and the potential for more resilient organic growth over the next several quarters.
GOJO Acquisition
GOJO adds the PURELL platform to Clorox’s health and hygiene portfolio and is already performing ahead of expectations. Expected revenue synergies and mid- to high-single-digit growth could broaden the growth base and improve earnings contribution over time.
Free Cash Flow
Positive free cash flow across the reported years, including $405 million in 2026, shows that the business can convert operations into funding. The targeted 11%–13% of sales range supports reinvestment, debt service, and continued shareholder distributions.
People also ask
What is the 12-month price target for Clorox (CLX)?
tipranks publishes an average 12-month price target of USD 90.15 (3.91% Upside), as SmartChecker read it on 2026-10-27. The highest target is USD 110 and the lowest is USD 74. A price target is an analyst’s estimate of where a share might trade, not a promise, and SmartChecker gives no investment advice.
See tipranks’s own page ↗How many analysts cover Clorox (CLX)?
tipranks records 14 analyst ratings: 0 buy, 10 hold and 4 sell, which it summarises as “Moderate Sell”, as SmartChecker read it on 2026-10-27.
See tipranks’s own page ↗What is the tipranks score for Clorox (CLX)?
tipranks scores it 3 out of 10 and calls that “Underperform”, as SmartChecker read it on 2026-10-27. The score is tipranks’s, not SmartChecker’s, and SmartChecker does not rate listed shares.
See tipranks’s own page ↗Is this SmartChecker’s own forecast for Clorox?
No. Every figure on this page is published by tipranks, copied on 2026-10-27 with a link to the original, and not recalculated. SmartChecker assesses financial companies in Malaysia against the public registers; it makes no forecast of its own and holds no licence to advise on securities.
See tipranks’s own page ↗Member reviews. Members’ own ratings and words, not SmartChecker’s rating.
These ratings and words are written by SmartChecker members and published immediately without administrator approval. SmartChecker does not rate listed companies: a rating here belongs to whoever wrote it, it counts towards no score of ours, and nothing in it is advice.
Disclaimer
SmartChecker provides informational and financial market news only and does not provide investment, financial or legal advice.
